Evaluation of in vitro drug-drug interactions of ivermectin and antimalarial compounds (2025)

Peer-Reviewed Study · Tipthara P, Kullasakboonsri R, Kobylinski KC, Tarning J · 2025

Tipthara P et al., 2025: Human liver microsome experiments testing 15 antimalarials against ivermectin metabolism, finding piperaquine, mefloquine, chloroquine, proguanil and lumefantrine substantially slow it. A directly measured in vitro interaction relevant to co-administration programmes.

Compounds that had a substantial DDI effect on the in vitro metabolism of ivermectin included piperaquine (98%), mefloquine (91%), chloroquine (76%), proguanil (60%), and lumefantrine (51%).

Tipthara P et al., 2025: Human liver microsome experiments testing 15 antimalarials against ivermectin metabolism, finding piperaquine, mefloquine, chloroquine, proguanil and lumefantrine substantially slow it. A directly measured in vitro interaction relevant to co-administration programmes. C6 measured in vitro DDI. Study type: in vitro human liver microsome experiment; no human subjects; Thailand (Mahidol Oxford Tropical Medicine Research Unit, Bangkok). Dose/concentrations: ivermectin 1 microM incubated with each antimalarial at two- to tenfold peak clinical concentrations. Comparator: ivermectin without antimalarial. Declared conflicts: authors state competing interests declared (text truncated in the capture; the declaration reads 'The authors de…'). Bearing SUPPORTS the claim that interactions are documented, with the caveat that this is microsomal, not clinical. Study type: lab.